The global STD home testing market is anticipated to grow at a considerable CAGR of around 4.7% during the forecast period.  The rising prevalence of STD diseases across the globe has driven the demand for STD home testing market to limit its transmission. This is due to fact that STDs impose a major health and economic burden on economies across the globe. According to the WHO, in 2019 every day, more than 1 million people get infected by STDs globally.   Each year there are an estimated 374 million new infections with 1 of 4 STIs, chlamydia, gonorrhea, syphilis, and trichomoniasis. Moreover, in 2020, there were 374 million new infections cases with one of four STIs: chlamydia (129 million), gonorrhea (82 million), syphilis (7.1 million), and trichomoniasis (156 million).

WHO has released ‘Global Health Sector Strategy on Sexually Transmitted Infections, 2016– 2021’ in 2016 aimed to reduce the incidence rate of syphilis and gonorrhea by 90.0% globally between 2018 and 2030; and to reduce the rates of congenital syphilis to less than 50 cases per 100 000 live births in 80.0% of countries. Such vision is supported by awareness programs such as Global AIDS Monitoring (GAM) and the Gonococcal Antimicrobial Susceptibility Programme (GASP) and extensive testing of STDs across the globe. However, the unavailability of reliable, low-cost, point-of-care (POC) tests, there is a demand for new technologies in the diagnosis field to provide precise testing results globally. The introduction of government initiatives to improve the healthcare infrastructure and increase awareness among the population regarding STDs prevention and control is boosting the STDs testing in emerging economies of Asia-Pacific and the Middle East, and Africa.

Impact of COVID-19 Pandemic on Global STD Home Testing Market 

COVID-19 significantly affected trends in STDs during 2020 resulting in likely underreporting of infections and possibly decreased STD transmission. The number of cases may be reduced due to a reduction in the screening of STDs, decreased routine healthcare visits, increased unemployment, and loss of health insurance, as well as STD test kit and laboratory supply shortages, which may have reduced screening during the pandemic. Moreover, the fear of being exposed to COVID-19 and limited access to public transportation also may have affected sexual behaviours and led to people with STD symptoms delaying care.

 Segmental Outlook 

The STD home testing market is segmented based on disease and sample. Based on disease, the market is segmented into chlamydia, syphilis, gonorrhea, herpes simplex virus, human papilloma virus (HPV), human immunodeficiency virus (HIV), and others. Based on sample type, the STD home testing market is segmented into blood-based, oral-fluid based, urine based, and other body fluid based. 

Global STD home testing market Market Share by Disease, 2021 (%)

Chlamydia held Considerable Share based on Disease Type

Chlamydia infection is the most commonly reported STD in the US. Various home Chlamydia STD test kits are available to detect Chlamydia infections. Everly Well provides at-home Chlamydia and Gonorrhea tests by using urine samples at around $49 cost. HIV is a virus that attacks the body's immune system. If HIV is not treated, it can lead to AIDS (acquired immunodeficiency syndrome). In May 2019, The Food and Drug Administration (FDA) cleared the Aptima Combo 2 Assay (Hologic) and the Xpert CT/NG (Cepheid) to detect chlamydia and gonorrhea via throat and rectum samples. 

Regional Outlooks

The global STD home testing market is further segmented based on geography including North America (the US, and Canada Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America).  The North America held considerable market share of XX% in STD Home Testing market. High patient awareness through education campaigns and growing government initiatives are some key factors that have driven the regional market growth. The presence of key market players across the region is further contributing to the growth of the regional market.

Global STD Home Testing Market Growth, by Region 2021-2028

Asia-Pacific will augment with the Significant Growth Rate in the STD Home Testing Market 

Asia-Pacific is anticipated to grow at a significant CAGR during the forecast period. The increasing prevalence of STD infected population, rising incidences of unprotected sex, and lack of awareness regarding STDs are some key factors that are leading towards the high demand for the STD home testing market in the region. Gonorrhea is the most dominant STD in the region, with a high incidence of chromosomally-mediated resistant and penicillinase-producing strains comprising around 35%-50% of isolates. Further, high clinical treatment failures due to spectinomycin-resistant gonococci are creating opportunities for the launch of new diagnostic technologies for gonorrhea in the region.  According to the UNAIDS report, an estimated 98% of new HIV infections, and more than one-quarter of new HIV infections were among young people (aged 15 to 24 years) in 2020, in Asia-Pacific region.  

Market Players Outlook

The major companies serving the global STD home testing market are Biosure (UK), Ltd., Everlywell, Inc., JAL Medical (Singapore) Pvt Ltd., Mylab Discovery Solutions Pvt. Ltd, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2022, Abbott received FDA clearance for its Alinity m STI(sexually transmitted infection)assay. The Alinity m STI is desgined to detect and differntialte four commen STIs, Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Trichomonas vaginalis (TV), and Mycoplasma genitalium (MG).

The Report Covers

• Market value data analysis of 2021 and forecast to 2028.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global STD home testing market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.